Upstate Active Clinical Trials
Study Title:Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
What is the purpose of the study?Randomized treatment study to compare the effectiveness of chemotherapy with or without monoclonal antibody, interleukin-2, and sargramostim following stem cell transplantation in treating patients who have neuroblastoma.
Upstate Institutional Review Board (IRB) Number:229602
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar